Emedastine Difumarate

富马酸依美斯汀

Report date: 2022/05/17 11:51:41
NME

Base Information

Drug NameEmedastine Difumarate
Drug Alias Name二福马酸依美斯汀Emedastine Fumarate组织胺Emedastinum依美斯汀富马酸盐 +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsUrticariaDermatitisDermatitis, Atopic +[5] 
Global Approved IndicationsUrticariaDermatitisDermatitis, Atopic +[5] 
Approved Indications in ChinaConjunctivitis, Allergic
Original Approved Country/TerritoryN/A
Original Approved Date1993/01/01
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesAlconImmedica Pharma Ab
Inactive CompaniesNovartis Pharma Ag
Active IndicationsUrticariaDermatitisDermatitis, Atopic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeS01GX06
Related LinksWikipediaDrugBankKEGG